Duxes is pleased to announce that the 5th Asia Pacific Healthcare Summit (HPAP) 2020 will take place in Singapore from June 18-19. The event is the leading annual platform for professionals engaged in the booming healthcare market and will offer a wide range of in-depth talks and discussions from industry experts, major companies, tech innovators and market analysts.
Everywhere you look, the Asia-Pacific
healthcare market is showing steady growth with no signs of stopping. The
market expanded to US$486.72 billion by the end of 2019. This year alone,
growth is projected to be 7.2% due to major increases in hospitals, home care
and medical tourism. Conventional drivers such as supportive government
regulations and policies are also a major source of support for the industry.
Broadly speaking, emerging markets such as
China, India and ASEAN are predicted to offer high-growth opportunities across
all segments. In the APAC region, however, healthcare challenges remain the
same – enabling access and making new technologies affordable demands complex
and innovative solutions from all industry stakeholders.
The two-day Summit will address numerous
key industry issues that deserve attention, including:
policy innovation, support for new business models, development of secure
interoperable technology platforms, and the evolving role of the consumer in
healthcare. These emerging trends have created growth opportunities for
industry participants including pharmaceuticals, diagnostics, medical
technology manufacturers, digital health vendors and healthcare service
providers.
The event will gather experts and other
stakeholders from China, Singapore, Japan, South Korea, Thailand, India,
Vietnam and other countries to share the latest healthcare findings and
developments, successful commercialization cases and viable business models,
market and consumer dynamics and future trends. Past contributors have included
Japan’s Ministry of Health, Labour and Welfare; the Medical Technology
Association of Australia; the Ministry of Health Malaysia; Ministry of Public
Health, Thailand; and, representatives from companies such as Philips, Johnson
& Johnson, GlaxoSmithKline, Sun Pharma and Bayer.
HPAP 2020 will provide attendees with
detailed information on the latest regulatory policies, growth opportunities
for healthcare across the APAC region, and offer a platform for healthcare
industry professionals to share experiences, and express opinions on optimal
business practices in the wake of changes within the industry. Professionals working
in the field of healthcare, pharmaceuticals, medical devices, insurance,
manufacturing and related fields, are invited to attend.
What you will learn?
- 100+
delegates interpreting healthcare regulations in Singapore, Japan, South Korea,
Thailand, India, Vietnam, and other major jurisdictions
- Firsthand
testimony from government officials and industry leaders on healthcare policy
in the APAC region and around the world, as well as future market trends
- Detailed
look at the registration process and market access strategy for healthcare
products
- In-depth
analysis of product development and clinical trial requirements in the
Asia-Pacific region
- Information
on cutting-edge innovation integrating drugs with medical devices
- Challenges
and opportunities for medical device supply chains and distributors
- Robust
exchange between company representatives and government regulators in the
interest of developing the industry
- Discussion
of regtech and digitalization
- Analysis
of emerging trends creating growth opportunities for industry participants
- Focus
on hot topics including policy innovation, support for new business models,
development of secure, interoperable technology platforms, and the evolving
role of consumers in healthcare
For further information, please contact:
Ms. Cindy CUI
Tel.: +86 21 5258 8005 Ext. 8253
Email: events@duxes.cn
Website: https://www.duxes-healthcare.com/